Jazz Pharmaceuticals plc Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax
Jazz Pharmaceuticals plc (JAZZ) reported Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax · last filed 2026-08-03
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2026-03-31 was -$100.00K, a 200.00% decline year-over-year.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2025-12-31 was $31.00K, a 87.65% decline year-over-year.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for the quarter ending 2025-09-30 was $129.00K, a 71.01% decline year-over-year.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2025 was $411.00K, a 74.20% decline from fiscal 2024.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2024 was $1.59M, a 40.11% increase from fiscal 2023.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2023 was $1.14M.
- Jazz Pharmaceuticals plc other comprehensive income (loss), cash flow hedge, gain (loss), before reclassification, tax for fiscal 2022 was $0.00.
| Period end | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 3 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 3 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 6 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 6 month as first filed | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 9 month | Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-03 | -$100.00K 10-Q · filed 2026-08-03 | -$69.00K derived: sum of 3 quarters · filed 2026-08-03 | $60.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2026-03-31 | -$100.00K 10-Q · filed 2026-05-05 | -$69.00K derived: sum of 2 quarters · filed 2026-05-05 | $60.00K derived: sum of 3 quarters · filed 2026-05-05 | $160.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $160.00K derived: sum of 2 quarters · filed 2026-02-24 | $260.00K derived: sum of 3 quarters · filed 2026-08-03 | $411.00K 10-K · filed 2026-02-24 | ||
| 2025-09-30 | $129.00K 10-Q · filed 2025-11-05 | $229.00K derived: sum of 2 quarters · filed 2026-08-03 | $380.00K 10-Q · filed 2025-11-05 | $580.00K derived: sum of 4 quarters · filed 2026-08-03 | ||
| 2025-06-30 | $100.00K 10-Q · filed 2026-08-03 | $119.00K 10-Q · filed 2025-08-06 | $200.00K 10-Q · filed 2026-08-03 | $251.00K 10-Q · filed 2025-08-06 | $451.00K derived: sum of 3 quarters · filed 2026-08-03 | $896.00K derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | $100.00K 10-Q · filed 2026-05-05 | $132.00K 10-Q · filed 2025-05-07 | $351.00K derived: sum of 2 quarters · filed 2026-05-05 | $796.00K derived: sum of 3 quarters · filed 2026-05-05 | $1.24M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $251.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $696.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.14M derived: sum of 3 quarters · filed 2026-02-24 | $1.59M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $445.00K 10-Q · filed 2025-11-05 | $891.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.34M 10-Q · filed 2025-11-05 | $1.79M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $446.00K 10-Q · filed 2025-08-06 | $897.00K 10-Q · filed 2025-08-06 | $1.35M derived: sum of 3 quarters · filed 2026-02-24 | $1.78M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $451.00K 10-Q · filed 2025-05-07 | $904.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.33M derived: sum of 3 quarters · filed 2026-02-24 | $1.59M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $453.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $881.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.14M derived: sum of 3 quarters · filed 2026-02-24 | $1.14M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $428.00K 10-Q · filed 2024-11-07 | $684.00K derived: sum of 2 quarters · filed 2024-11-07 | $684.00K 10-Q · filed 2024-11-07 | $684.00K derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-06-30 | $256.00K 10-Q · filed 2024-08-01 | $256.00K 10-Q · filed 2024-08-01 | $256.00K derived: sum of 3 quarters · filed 2025-02-26 | $256.00K derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 derived: sum of 4 quarters · filed 2025-02-26 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $0.00 derived: sum of 2 quarters · filed 2025-02-26 | $0.00 derived: sum of 3 quarters · filed 2025-02-26 | $0.00 10-K · filed 2025-02-26 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$22.00K derived: sum of 2 quarters · filed 2024-02-28 | -$189.00K derived: sum of 3 quarters · filed 2024-02-28 | -$355.00K 10-K · filed 2024-02-28 | ||
| 2021-09-30 | -$22.00K 10-Q · filed 2022-11-09 | -$189.00K derived: sum of 2 quarters · filed 2022-11-09 | -$355.00K 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$167.00K 10-Q · filed 2022-08-03 | -$333.00K 10-Q · filed 2022-08-03 | ||||
| 2020-12-31 | -$486.00K 10-K · filed 2023-03-01 | |||||
| 2020-06-30 | $85.00K 10-Q · filed 2020-08-04 | -$449.00K 10-Q · filed 2020-08-04 | $736.00K derived: sum of 3 quarters · filed 2020-08-04 | $656.00K derived: sum of 4 quarters · filed 2020-08-04 | ||
| 2020-03-31 | $579.00K 10-Q · filed 2020-05-05 | $651.00K derived: sum of 2 quarters · filed 2020-05-05 | $571.00K derived: sum of 3 quarters · filed 2020-05-05 | $131.00K derived: sum of 4 quarters · filed 2020-08-04 | ||
| 2019-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$8.00K derived: sum of 2 quarters · filed 2020-02-25 | -$448.00K derived: sum of 3 quarters · filed 2020-08-04 | -$697.00K 10-K · filed 2020-02-25 | ||
| 2019-09-30 | -$80.00K 10-Q · filed 2019-11-05 | -$520.00K derived: sum of 2 quarters · filed 2020-08-04 | -$769.00K 10-Q · filed 2019-11-05 | -$740.00K derived: sum of 4 quarters · filed 2020-08-04 | ||
| 2019-06-30 | -$440.00K 10-Q · filed 2020-08-04 | -$689.00K 10-Q · filed 2020-08-04 | -$660.00K derived: sum of 3 quarters · filed 2020-08-04 | -$553.00K derived: sum of 4 quarters · filed 2020-08-04 | ||
| 2019-03-31 | $249.00K 10-Q · filed 2020-05-05 | -$249.00K 10-Q · filed 2019-05-07 | -$220.00K derived: sum of 2 quarters · filed 2020-05-05 | -$113.00K derived: sum of 3 quarters · filed 2020-05-05 | $80.00K derived: sum of 4 quarters · filed 2020-05-05 | |
| 2018-12-31 | -$469.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$362.00K derived: sum of 2 quarters · filed 2020-02-25 | -$169.00K derived: sum of 3 quarters · filed 2020-02-25 | $289.00K 10-K · filed 2020-02-25 | ||
| 2018-09-30 | $107.00K 10-Q · filed 2019-11-05 | $300.00K derived: sum of 2 quarters · filed 2019-11-05 | $758.00K 10-Q · filed 2019-11-05 | $1.11M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-06-30 | $193.00K 10-Q · filed 2019-08-06 | $651.00K 10-Q · filed 2019-08-06 | $1.00M derived: sum of 3 quarters · filed 2020-02-25 | $1.06M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-31 | $458.00K 10-Q · filed 2019-05-07 | $807.00K derived: sum of 2 quarters · filed 2020-02-25 | $863.00K derived: sum of 3 quarters · filed 2020-02-25 | $759.00K derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $349.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $405.00K derived: sum of 2 quarters · filed 2020-02-25 | $301.00K derived: sum of 3 quarters · filed 2020-02-25 | $212.00K 10-K · filed 2020-02-25 | ||
| 2017-09-30 | $56.00K 10-Q · filed 2018-11-06 | -$48.00K derived: sum of 2 quarters · filed 2018-11-06 | -$137.00K 10-Q · filed 2018-11-06 | |||
| 2017-06-30 | -$104.00K 10-Q · filed 2018-08-07 | -$193.00K 10-Q · filed 2018-08-07 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |